Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 47.19 K87.17 K152.96 K178.74 K185.84 K340.36 K 857.9 K Research & development —————— — Operating income -47.19 K-87.17 K-152.96 K-178.74 K-185.84 K-340.36 K -857.9 K Non-Operating Income, Total 0-273.52 K2.26 M2.11 M1.94 M1.97 M 8.28 M Interest expense, net of interest capitalized —————— — Non-Operating Income, excl. Interest Expenses 0-273.52 K2.26 M2.11 M1.94 M1.97 M 8.28 M Unusual income/expense —————— — Pretax income -47.19 K-360.69 K2.11 M1.93 M1.76 M1.63 M 7.43 M Equity in earnings —————— — Taxes —————— — Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations -47.19 K-360.69 K2.11 M1.93 M1.76 M1.63 M 7.43 M Discontinued operations —————— — Net income -47.19 K-360.69 K2.11 M1.93 M1.76 M1.63 M 7.43 M Dilution adjustment ——217.98 M—222.01 M223.98 M — Preferred dividends ——217.98 M—222.01 M223.98 M — Diluted net income available to common stockholders 47.19 K360.69 K2.11 M1.12 M1.76 M1.63 M 6.61 M Basic earnings per share (Basic EPS) 0.010.090.120.160.240.2 0.72 Diluted earnings per share (Diluted EPS) 0.010.090.10.160.240.2 0.7 Average basic shares outstanding 6.88 M7.6 M15.81 M19.62 M30.07 M60.15 M — Diluted shares outstanding 6.88 M8.6 M16.44 M19.88 M30.07 M60.15 M — EBITDA —————— — EBIT —————— — Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) —————— —